Cyclic peptide FXII inhibitor provides safe anticoagulation in a thrombosis model and in artificial lungs

Inhibiting thrombosis without inducing bleeding is a major challenge for anticoagulant agents. Here the authors describe a synthetic FXIIa inhibitor able to efficiently prevent thrombosis in mice and suppress coagulation in artificial lungs in rabbits without increasing the risk of bleeding.

Bibliographic Details
Main Authors: Jonas Wilbs, Xu-Dong Kong, Simon J. Middendorp, Raja Prince, Alida Cooke, Caitlin T. Demarest, Mai M. Abdelhafez, Kalliope Roberts, Nao Umei, Patrick Gonschorek, Christina Lamers, Kaycie Deyle, Robert Rieben, Keith E. Cook, Anne Angelillo-Scherrer, Christian Heinis
Format: Article
Language:English
Published: Nature Publishing Group 2020-08-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-020-17648-w
id doaj-1f9ddb75be1e4a398c1ff63698dcaa1b
record_format Article
spelling doaj-1f9ddb75be1e4a398c1ff63698dcaa1b2021-08-08T11:38:57ZengNature Publishing GroupNature Communications2041-17232020-08-0111111310.1038/s41467-020-17648-wCyclic peptide FXII inhibitor provides safe anticoagulation in a thrombosis model and in artificial lungsJonas Wilbs0Xu-Dong Kong1Simon J. Middendorp2Raja Prince3Alida Cooke4Caitlin T. Demarest5Mai M. Abdelhafez6Kalliope Roberts7Nao Umei8Patrick Gonschorek9Christina Lamers10Kaycie Deyle11Robert Rieben12Keith E. Cook13Anne Angelillo-Scherrer14Christian Heinis15Institute of Chemical Sciences and Engineering, Ecole Polytechnique Fédérale de Lausanne (EPFL)Institute of Chemical Sciences and Engineering, Ecole Polytechnique Fédérale de Lausanne (EPFL)Institute of Chemical Sciences and Engineering, Ecole Polytechnique Fédérale de Lausanne (EPFL)Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, University of BernDepartment of Biomedical Engineering, Carnegie Mellon UniversityDepartment of Biomedical Engineering, Carnegie Mellon UniversityDepartment of Clinical Research, University of BernDepartment of Biomedical Engineering, Carnegie Mellon UniversityDepartment of Biomedical Engineering, Carnegie Mellon UniversityInstitute of Chemical Sciences and Engineering, Ecole Polytechnique Fédérale de Lausanne (EPFL)Institute of Chemical Sciences and Engineering, Ecole Polytechnique Fédérale de Lausanne (EPFL)Institute of Chemical Sciences and Engineering, Ecole Polytechnique Fédérale de Lausanne (EPFL)Department of Clinical Research, University of BernDepartment of Biomedical Engineering, Carnegie Mellon UniversityDepartment of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, University of BernInstitute of Chemical Sciences and Engineering, Ecole Polytechnique Fédérale de Lausanne (EPFL)Inhibiting thrombosis without inducing bleeding is a major challenge for anticoagulant agents. Here the authors describe a synthetic FXIIa inhibitor able to efficiently prevent thrombosis in mice and suppress coagulation in artificial lungs in rabbits without increasing the risk of bleeding.https://doi.org/10.1038/s41467-020-17648-w
collection DOAJ
language English
format Article
sources DOAJ
author Jonas Wilbs
Xu-Dong Kong
Simon J. Middendorp
Raja Prince
Alida Cooke
Caitlin T. Demarest
Mai M. Abdelhafez
Kalliope Roberts
Nao Umei
Patrick Gonschorek
Christina Lamers
Kaycie Deyle
Robert Rieben
Keith E. Cook
Anne Angelillo-Scherrer
Christian Heinis
spellingShingle Jonas Wilbs
Xu-Dong Kong
Simon J. Middendorp
Raja Prince
Alida Cooke
Caitlin T. Demarest
Mai M. Abdelhafez
Kalliope Roberts
Nao Umei
Patrick Gonschorek
Christina Lamers
Kaycie Deyle
Robert Rieben
Keith E. Cook
Anne Angelillo-Scherrer
Christian Heinis
Cyclic peptide FXII inhibitor provides safe anticoagulation in a thrombosis model and in artificial lungs
Nature Communications
author_facet Jonas Wilbs
Xu-Dong Kong
Simon J. Middendorp
Raja Prince
Alida Cooke
Caitlin T. Demarest
Mai M. Abdelhafez
Kalliope Roberts
Nao Umei
Patrick Gonschorek
Christina Lamers
Kaycie Deyle
Robert Rieben
Keith E. Cook
Anne Angelillo-Scherrer
Christian Heinis
author_sort Jonas Wilbs
title Cyclic peptide FXII inhibitor provides safe anticoagulation in a thrombosis model and in artificial lungs
title_short Cyclic peptide FXII inhibitor provides safe anticoagulation in a thrombosis model and in artificial lungs
title_full Cyclic peptide FXII inhibitor provides safe anticoagulation in a thrombosis model and in artificial lungs
title_fullStr Cyclic peptide FXII inhibitor provides safe anticoagulation in a thrombosis model and in artificial lungs
title_full_unstemmed Cyclic peptide FXII inhibitor provides safe anticoagulation in a thrombosis model and in artificial lungs
title_sort cyclic peptide fxii inhibitor provides safe anticoagulation in a thrombosis model and in artificial lungs
publisher Nature Publishing Group
series Nature Communications
issn 2041-1723
publishDate 2020-08-01
description Inhibiting thrombosis without inducing bleeding is a major challenge for anticoagulant agents. Here the authors describe a synthetic FXIIa inhibitor able to efficiently prevent thrombosis in mice and suppress coagulation in artificial lungs in rabbits without increasing the risk of bleeding.
url https://doi.org/10.1038/s41467-020-17648-w
work_keys_str_mv AT jonaswilbs cyclicpeptidefxiiinhibitorprovidessafeanticoagulationinathrombosismodelandinartificiallungs
AT xudongkong cyclicpeptidefxiiinhibitorprovidessafeanticoagulationinathrombosismodelandinartificiallungs
AT simonjmiddendorp cyclicpeptidefxiiinhibitorprovidessafeanticoagulationinathrombosismodelandinartificiallungs
AT rajaprince cyclicpeptidefxiiinhibitorprovidessafeanticoagulationinathrombosismodelandinartificiallungs
AT alidacooke cyclicpeptidefxiiinhibitorprovidessafeanticoagulationinathrombosismodelandinartificiallungs
AT caitlintdemarest cyclicpeptidefxiiinhibitorprovidessafeanticoagulationinathrombosismodelandinartificiallungs
AT maimabdelhafez cyclicpeptidefxiiinhibitorprovidessafeanticoagulationinathrombosismodelandinartificiallungs
AT kallioperoberts cyclicpeptidefxiiinhibitorprovidessafeanticoagulationinathrombosismodelandinartificiallungs
AT naoumei cyclicpeptidefxiiinhibitorprovidessafeanticoagulationinathrombosismodelandinartificiallungs
AT patrickgonschorek cyclicpeptidefxiiinhibitorprovidessafeanticoagulationinathrombosismodelandinartificiallungs
AT christinalamers cyclicpeptidefxiiinhibitorprovidessafeanticoagulationinathrombosismodelandinartificiallungs
AT kayciedeyle cyclicpeptidefxiiinhibitorprovidessafeanticoagulationinathrombosismodelandinartificiallungs
AT robertrieben cyclicpeptidefxiiinhibitorprovidessafeanticoagulationinathrombosismodelandinartificiallungs
AT keithecook cyclicpeptidefxiiinhibitorprovidessafeanticoagulationinathrombosismodelandinartificiallungs
AT anneangelilloscherrer cyclicpeptidefxiiinhibitorprovidessafeanticoagulationinathrombosismodelandinartificiallungs
AT christianheinis cyclicpeptidefxiiinhibitorprovidessafeanticoagulationinathrombosismodelandinartificiallungs
_version_ 1721215707347156992